Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Retifanlimab-Chemo Combo Boosts PFS in Advanced Squamous Cell Anal Cancer

2.

AI-Driven Biomarker Predicts Prostate Cancer Outcomes

3.

Legal, Recreational Marijuana Linked to Higher CUD Prevalence.

4.

Knowing about and avoiding bladder cancer.

5.

Mobile prostate cancer screening clinic can ID the disease in disadvantaged men


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot